Site Map
General Information
Center Directory
News and Events
Grants and Publications
Employment
E-mail access for CRCH Staff only
Cancer Research Center of Hawaii

<<Previous - Index
Next - In Press Publications>>
2002 Publications

  1. Health Behavior and Health Education. 3rd ed. San Francisco: Jossey-Bass; 2002.
  2. Andra J, Halter R, Kock MA, Niemann H, Vogel CW, Paul D. Generation and characterization of transgenic mice expressing cobra venom factor. Mol Immunol. 2002;39:357-65.
  3. Auld G, Boushey CJ, Bock MA, Bruhn C, Gabel K, Gustafson D et al. Perspectives on intake of calcium-rich foods among Asian, Hispanic, and white preadolescent and adolescent females. J Nutr Educ Behav. 2002;34:242-51.
  4. Barr SI, Murphy SP, Poos MI. Interpreting and using the dietary references intakes in dietary assessment of individuals and groups. J Am Diet Assoc. 2002;102:780-788.
  5. Benhamou S, Lee WJ, Alexandrie AK, Boffetta P, Bouchardy C, Butkiewicz D et al. Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis. 2002;23:1343-50.
  6. Bosetti C, Negri E, Kolonel L, Ron E, Franceschi S, Preston-Martin S et al. A pooled analysis of case-control studies of thyroid cancer. VII. Cruciferous and other vegetables (International). Cancer Causes Control. 2002;13:765-75.
  7. Boshuizen HC, Bueno-de-Mesquita HB, Altenburg HP, Agudo A, Le Marchand L, Berrino F et al. Adjustment for smoking in lung cancer analyses in the EPIC cohort. IARC Sci Publ. 2002;156:59-61.
  8. Braun KL, Mokuau N, Hunt GH, Kaanoi M, Gotay CC. Supports and obstacles to cancer survival for Hawaii's native people. Cancer Pract. 2002;10:192-200.
  9. Browne CV, Braun KL, Mokuau N, McLaughlin L. Developing a multisite project in geriatric and/or gerontological education with emphases in interdisciplinary practice and cultural competence. Gerontologist. 2002;42:698-704.
  10. Burbank PM, Reibe D, Padula CA, Nigg C. Exercise and older adults: changing behavior with the transtheoretical model. Orthop Nurs. 2002;21:51-61.
  11. Clark PG, Nigg CR, Greene G, Riebe D, Saunders SD. The Study of Exercise and Nutrition in Older Rhode Islanders (SENIOR): translating theory into research. Health Educ Res. 2002;17:552-61.
  12. Collaborative Group on Hormonal Factors in Breast Cancer, Kolonel LM, Nomura AMY. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet. 2002;360:187-95.
  13. Csiszar K, Fong SF, Ujfalusi A, Krawetz SA, Salvati EP, Mackenzie JW et al. Somatic mutations of the lysyl oxidase gene on chromosome 5q23.1 in colorectal tumors. Int J Cancer. 2002;97:636-42.
  14. Dai Q, Franke AA, Jin F, Shu XO, Hebert JR, Custer LJ et al. Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai. Cancer Epidemiol Biomarkers Prev. 2002;11:815-21.
  15. Donlon TA. Chromosome 14. Wiley Encyclopedia of Molecular Medicine. John Wiley & Sons, Inc; 2002: 812-14.
  16. Falk RT, Fears TR, Hoover RN, Pike MC, Wu AH, Nomura AM et al. Does place of birth influence endogenous hormone levels in Asian- American women? Br J Cancer. 2002;87:54-60.
  17. Fong KSK, Csiszar K, Elmer E. Cyclosporin A prolongs survival of SOD1 mutant mice and implicates the mitochondrial permeability transition in ALS. In: Borlongan C, ed. Immunosuppressants in Neurological Disorders. Human Press; 2002: in press.
  18. Franke AA, Custer LJ, Cooney RV, Tanaka Y, Xu M, Dashwood RH. Inhibition of colonic aberrant crypt formation by the dietary flavonoids (+)-catechin and hesperidin. Adv Exp Med Biol. 2002;505:123-33.
  19. Franke AA, Custer LJ, Wilkens LR, Le Marchand LL, Nomura AM, Goodman MT et al. Liquid chromatographic-photodiode array mass spectrometric analysis of dietary phytoestrogens from human urine and blood. J Chromatogr B Analyt Technol Biomed Life Sci. 2002;777:45-59.
  20. Franke AA, Murphy SP, Le Marchand L, Zheng W, Custer LJ. Liquid chromatography analysis of dietary phytoestrogens including isoflavonoids and lignans in foods and human body fluids. J Nutr. 2002;132:592s.
  21. Glanz K, Geller AC, Shigaki D, Maddock JE, Isnec MR. A randomized trial of skin cancer prevention in aquatics settings: the Pool Cool program. Health Psychol. 2002;21:579-87.
  22. Glanz K, Saraiya M, Wechsler H. Guidelines for school programs to prevent skin cancer. MMWR Recomm Rep. 2002;51:1-18.
  23. Glanz K, Maddock J. Health related behavior. In: Breslow L, Green LW, Keck W, Last J, Lave L, McGinnis M, eds. Encyclopedia of Public Health. New York: MacMillian Reference USA; 2002: 98-104.
  24. Glanz K. Perspectives on group, organization and community interventions. In: Glanz K, Rimer B, Lewis FM, eds. Health Behavior and Health Education: Theory, Research, and Practice. 3rd ed. Jossey-Bass, Inc.; 2002: 389-403.
  25. Glanz K. Perspectives on using theory: past, present and future. In: Glanz K, Rimer B, Lewis FM, eds. Health Behavior and Health Education: Theory, Research, and Practice. 3rd ed. Jossey-Bass, Inc; 2002: 545-58.
  26. Glanz K, Isnec MR, Geller A, Spangler K. Process evaluation of implementation and dissemination of a sun safety program at swimming pools. In: Steckler A, Linnan L, eds. Process Evaluation in Public Health Interventions. San Francisco: Jossey-Bass,Inc; 2002: 58-82.
  27. Gong G, Oakley-Girvan I, Wu AH, Kolonel LN, John EM, West DW et al. Segregation analysis of prostate cancer in 1,719 white, African- American and Asian-American families in the United States and Canada. Cancer Causes Control. 2002;13:471-82.
  28. Goodman MT, Wu AH, Tung KH, McDuffie K, Kolonel LN, Nomura AM et al. Association of dairy products, lactose, and calcium with the risk of ovarian cancer. Am J Epidemiol. 2002;156:148-57.
  29. Goodman MT, Wu AH, Tung KH, McDuffie K, Cramer DW, Wilkens LR et al. Association of galactose-1-phosphate uridyltransferase activity and N314D genotype with the risk of ovarian cancer. Am J Epidemiol. 2002;156:693-701.
  30. Gotay CC, Blaine D, Haynes SN, Holup J, Pagano IS. Assessment of quality of life in a multicultural cancer patient population. Psychol Assess. 2002;14:439-50.
  31. Gotay CC, Holup JL, Pagano I. Ethnic differences in quality of life among early breast and prostate cancer survivors. Psychooncology. 2002;11:103-13.
  32. Gotay CC, Holup JL, Muraoka M. The challenges of prostate cancer: a major men's health issur. Int J Men's Health. 2002;1:59-72.
  33. Hamajima N, Hirose K, Tajima K, Rohan T, Calle EE, Heath CW, Jr. et al. Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer. 2002;87:1234-45.
  34. Harrington PE, Murai T, Chu C, Tius MA. Asymmetric cyclopentannelation: camphor-derived auxiliary. J Am Chem Soc. 2002;124:10091-100.
  35. Hasenblas HA, Nigg CR, Symons DA, Fleming DS, Connaughton DP. Perceptions of exercise stages, barrier self-efficacy, and decisional balence for middle-level school students. J Early Adolescence. 2002;22:436-54.
  36. Hernandez BY. The Hawaii Tumor Registry: more than forty years of cancer surveillance for the islands. Hawaii Med J. 2002;61:53.
  37. Hundahl SA. Staging, stage migration, and patterns of spread in gastric cancer. Semin Radiat Oncol. 2002;12:141-49.
  38. Hundahl SA. Surgical quality control in gastric cancer trials. Surg Oncol Clinics North Am. 2002;13:1-14.
  39. Hundahl SA, Macdonald JS, Benedetti J, Fitzsimmons T. Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment. Ann Surg Oncol. 2002;9:278-86.
  40. Hundahl SA, Fleming ID, Shah JP. Thyroid cancer. In: Steele JD, Jr., Jessup JM, Winchester DP, Menck HR, Murphy GP, eds. National Cancer Data Base, Annual Review of Patient Care, 1995. American Cancer Society; 2002: 100-112.
  41. Ilias A, Urban Z, Seidl TL, Le Saux O, Sinko E, Boyd CD et al. Loss of ATP-dependent transport activity in pseudoxanthoma elasticum- associated mutants of human ABCC6 (MRP6). J Biol Chem. 2002;277:16860-16867.
  42. Kaanoi M, Braun KL, Gotay CC, Abrigo L. Oncologists' knowledge, attitudes and practices related to cancer treatment clinical trials. Hawaii Med J. 2002;61:91-95.
  43. Keith SK, Fong K, Csiszar K, Elmer E. Cyclosporin A prolongs survival of SOD1 mutant mice and implicates the mitochondrial permeability transition in ALS. In: Borlongan C, ed. Immunosuppressants in Neurological Disorders. Humana Press; 2002.
  44. King TJ, Fukushima LH, Yasui Y, Lampe PD, Bertram JS. Inducible expression of the gap junction protein connexin43 decreases the neoplastic potential of HT-1080 human fibrosarcoma cells in vitro and in vivo. Mol Carcinog. 2002;35:29-41.
  45. Kirschmann DA, Seftor EA, Fong SF, Nieva DR, Sullivan CM, Edwards EM et al. A molecular role for lysyl oxidase in breast cancer invasion. Cancer Res. 2002;62:4478-83.
  46. Kucuk O, Sarkar FH, Djuric Z, Sakr W, Pollak MN, Khachik F et al. Effects of lycopene supplementation in patients with localized prostate cancer. Exp Biol Med (Maywood ). 2002;227:881-85.
  47. Kucuk O, Sarkar FH, Sakr W, Khachik F, Djuric Z, Banerjee M et al. Lycopene in the treatment of prostate cancer. Pure Appl Chem. 2002;74:1143-50.
  48. Lawson JS, Field AS, Tran DD, Killeen J, Maskarinec G, Ishikuba H et al. Breast cancer incidence and estrogen receptor A in normal mammary tissue - an epidemiologic study among Japanese women in Japan and Hawaii. Int J Cancer. 2002;97:685-87.
  49. Le Marchand L, Donlon T, Seifried A, Kaaks R, Rinaldi S, Wilkens LR. Association of a common polymorphism in the hGH-I gene and colorectal neoplasia. J Natl Cancer Inst. 2002;94:454-60.
  50. Le Marchand L, Donlon T, Lum-Jones A, Seifried A, Wilkens LR. Association of the hOGG1 Ser326Cyst polymorphism with lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2002;11:409-12.
  51. Le Marchand L, Donlon T, Hankin JH, Kolonel LN, Wilkens LR, Seifried A. B-vitamin intake, metabolic genes, and colorectal cancer risk (United States). Cancer Causes Control. 2002;13:239-48.
  52. Le Marchand L. Cancer preventive effects of flavonoids - a review. Biomed Pharmacother. 2002;56:296-301.
  53. Le Marchand L, Boffetta P. Lung, larynx, oral cavity, pharynx. In: Bertino JR, ed. Encyclopedia of Cancer. 2nd ed. San Diego: Academic Press; 2002: 51-58.
  54. Le Marchand L. Meat intake, metabolic genes and colorectal cancer. IARC Sci Publ. 2002;156:481-85.
  55. Le Marchand L, Donlon T, Seifried A, Wilkens LR. Red meat intake, CYP2E1 genetic polymorphisms, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2002;11:1019-24.
  56. Le Marchand L, Hankin JH, Pierce LM, Sinha R, Nerurkar PV, Franke AA et al. Well-done red meat, metabolic phenotypes and colorectal cancer in Hawaii. Mutat Res. 2002;506-507:205-14.
  57. Le Saux O, Beck K, Sachsinger C, Treiber C, Goring HH, Curry K et al. Evidence for a founder effect for pseudoxanthoma elasticum in the Afrikaner population of South Africa. Hum Genet. 2002;111:331-38.
  58. Levintova-Romero M, Gotay CC. Pain assessment in Hawaii nursing homes. Hawaii Med J. 2002;61:121-23.
  59. Li LH, Tius MA. Stereospecific synthesis of cryptophycin 1. Org Lett. 2002;4:1637-40.
  60. Lin HJ, Lakkides KM, Keku TO, Reddy ST, Louie AD, Kau IH et al. Prostaglandin H synthase 2 variant (Val511Ala) in African Americans may reduce the risk for colorectal neoplasia. Cancer Epidemiol Biomarkers Prev. 2002;11:1305-15.
  61. Luesch H, Yoshida WY, Harrigan GG, Doom JP, Moore RE, Paul VJ. Lyngbyaloside B, a new glycoside macrolide from a Palauan marine cyanobacterium, Lyngbya sp. J Nat Prod. 2002;65:1945-48.
  62. Luesch H, Yoshida WY, Moore RE, Paul VJ. New apratoxins of marine cyanobacterial origin from Guam and Palau. Bioorg Med Chem. 2002;10:1973-78.
  63. Luesch H, Yoshida WY, Moore RE, Paul VJ, Mooberry SL, Corbett TH. Symplostatin 3, a new dolastatin 10 analogue from the marine cyanobacterium Symploca sp. VP452. J Nat Prod. 2002;65:16-20.
  64. Luesch H, Williams PG, Yoshida WY, Moore RE, Paul VJ. Ulongamides A-F, new beta-amino acid-containing cyclodepsipeptides from Palauan collections of the marine cyanobacterium Lyngbya sp. J Nat Prod. 2002;65:996-1000.
  65. Macdonald JS, Benedetti J, Hundahl SA. letter. N Eng J Med. 2002;346:211.
  66. Maskarinec G, Williams AE, Inouye JS, Stanczyk FZ, Franke AA. A randomized isoflavone intervention among premenopausal women. Cancer Epidemiol Biomarkers Prev. 2002;11:195-201.
  67. Maskarinec G, Nagata C, Shimizu H, Kashiki Y. Comparison of mammographic densities and their determinants in women from Japan and Hawaii. Int J Cancer. 2002;102:29-33.
  68. Maskarinec G, Franke AA, Williams AE, Stanczyk FC. The effects of an isoflavone intervention on the urinary excretion of hormone metabolites in premenopausal women. IARC Sci Publ. 2002;156:375-77.
  69. Maskarinec G, Dhakal S, Yamashiro G, Issell BF. The use of breast conserving surgery: linking insurance claims with tumor registry data. BMC Cancer. 2002;2:3.
  70. McClatchey, W. Biogeographical observation of Metroxylon section Coelococcus. Kainuma, K., Okazaki, M., Toyoda, Y., and Cecil, J. E.  119-126. 2002. Tokyo, Universal Academy Press. Frontiers of Sago Palm Studies, Proceedings of the International Symposium on Sago. A New Bidge Linking South and North.
  71. McClatchey, W. Diversity of growth forms and uses in the Morinda citrifolia L. complex. Nelson, S. C.  2002. Honolulu, Hawaii. Proceedings of the 2002 Hawaii Noni Conference.
  72. McClatchey W. From Polynesian healers to health food stores: changing ethnopharmacology of Morinda citrifolia. J Integrative Cancer Therapy. 2002;1:110-120.
  73. Murphy SP, Wilkens LR, Hankin JH, Foote JA, Monroe KR, Henderson BE et al. Comparison of two instruments for quantifying intake of vitamin and mineral supplements: a brief questionnaire versus three 24-hour recalls. Am J Epidemiol. 2002;156:669-75.
  74. Murphy SP. Dietary reference intakes for the U.S. and Canada: update on implications for nutrient databases. J Food Comp Anal. 2002;15:411-17.
  75. Murphy SP, Poos MI. Dietary Reference Intakes: summary of applications in dietary assessment. Public Health Nutr. 2002;5:843-49.
  76. Murphy SP, Barr SI, Poos MI. Using the new dietary reference intakes to assess diets: a map to the maze. Nutr Rev. 2002;60:267-75.
  77. Nakazaki A, Sharma U, Tius MA. Synthesis of the hydroazulene portion of guanacastepene A from the cyclopentannelation reaction. Org Lett. 2002;4:3363-66.
  78. Negri E, Ron E, Franceschi S, La Vecchia C, Preston-Martin S, Kolonel L et al. Risk factors for medullary thyroid carcinoma: a pooled analysis. Cancer Causes Control. 2002;13:365-72.
  79. Ness RB, Cramer DW, Goodman MT, Kjaer SK, Mallin K, Mosgaard BJ et al. Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. Am J Epidemiol. 2002;155:217-24.
  80. Nigg CR, Allegrante JP, Ory M. Theory-comparison and multiple-behavior research: common themes advancing health behavior research. Health Educ Res. 2002;17:670-679.
  81. Nomura AM, Lee J, Stemmermann GN, Nomura RY, Perez-Perez GI, Blaser MJ. Helicobacter pylori CagA seropositivity and gastric carcinoma risk in a Japanese American population. J Infect Dis. 2002;186:1138-44.
  82. Nomura AM, Perez-Perez GI, Lee J, Stemmermann G, Blaser MJ. Relation between Helicobacter pylori cagA status and risk of peptic ulcer disease. Am J Epidemiol. 2002;155:1054-59.
  83. Pearce CL, Makridakis NM, Ross RK, Pike MC, Kolonel LN, Henderson BE et al. Steroid 5-alpha reductase type II V89L substitution is not associated with risk of prostate cancer in a multiethnic population study. Cancer Epidemiol Biomarkers Prev. 2002;11:417-18.
  84. Pierce BT, Calhoun BC, Adolphson KR, Lau AF, Pierce LM. Connexin 43 expression in normal versus dysfunctional labor. Am J Obstet Gynecol. 2002;186:504-11.
  85. Pike MC, Kolonel LN, Henderson BE, Wilkens LR, Hankin JH, Feigelson HS et al. Breast cancer in a multiethnic cohort in Hawaii and Los Angeles: risk factor-adjusted incidence in Japanese equals and in Hawaiians exceeds that in whites. Cancer Epidemiol Biomarkers Prev. 2002;11:795-800.
  86. Ratnayake AS, Hemscheidt T. Olefin cross-metathesis as a tool in natural product degradation. The stereochemistry of (+)-falcarindiol. Org Lett. 2002;4:4667-69.
  87. Resnicow K, Braithwaite R, Dilorio C, Glanz K. Applying theory to culturally diverse and unique populations. In: Glanz K, Rimer B, Lewis FM, eds. Health Behavior and Health Education: Theory, Research, and Practice. 3rd ed. Jossey-Bass, Inc; 2002: 485-509.
  88. Rong SB, Enyedy IJ, Qiao L, Zhao L, Ma D, Pearce LL et al. Structural basis of RasGRP binding to high-affinity PKC ligands. J Med Chem. 2002;45:853-60.
  89. Schultz-Fademrecht C, Tius MA, Grimme S, Wibbeling B, Hoppe D. Synthesis of enantioenriched 5-alkylidene-2-cyclopentenones from chiral allenyl carbamates: generation of a chiral lithium allenolate and allylic activation for a conrotary 4-electrocyclization. Ang Chem Int Ed. 2002;41:1532-35.
  90. Schumann A, Nigg CR, Rossi JS, Jordan PJ, Norman GJ, Garber CE et al. Construct validity of the stages of change of exercise adoption for different intensities of physical activity in four samples of differing age groups. Am J Health Promot. 2002;16:280-287.
  91. Sharma S, Cade J, Landman J, Cruickshank JK. Assessing the diet of the British African-Caribbean population: frequency of consumption of foods and food portion sizes. Int J Food Sci Nutr. 2002;53:439-44.
  92. Shigemasa S, Vogel CW. The role of NCI-designated cancer centers in the nation's fight against cancer. Hawaii Med J. 2002;61:104-5.
  93. Shumay DM, Maskarinec G, Gotay CC, Heiby EM, Kakai H. Determinants of the degree of complementary and alternative medicine use among patients with cancer. J Altern Complement Med. 2002;8:661-71.
  94. Stemmermann GN, Nomura AM, Kolonel LN, Goodman MT, Wilkens LR. Gastric carcinoma: pathology findings in a multiethnic population. Cancer. 2002;95:744-50.
  95. Tasaki K, Maskarinec G, Shumay DM, Tatsumura Y, Kakai H. Communication between physicians and cancer patients about complementary and alternative medicine: exploring patients' perspectives. Psychooncology. 2002;11:212-20.
  96. Thakur GA, Palmer SL, Harrington PE, Stergiades IA, Tius MA, Makriyannis A. Enantiomeric resolution of a novel chiral cannabinoid receptor ligand. J Biochem Biophys Methods. 2002;54:415-22.
  97. Tius MA. Synthesis of the cryptophycin 1. Tetrahedron. 2002;58:4343-67.
  98. Urban Z, Riazi S, Seidl TL, Katahira J, Smoot LB, Chitayat D et al. Connection between elastin haploinsufficiency and increased cell proliferation in patients with supravalvular aortic stenosis and Williams-Beuren syndrome. Am J Hum Genet. 2002;71:30-44.
  99. Urschitz J, Iobst S, Urban Z, Granda C, Souza KA, Lupp C et al. A serial analysis of gene expression in sun-damaged human skin. J Invest Dermatol. 2002;119:3-13.
  100. Vine AL, Bertram JS. Cancer chemoprevention by connexins. Cancer Metastasis Rev. 2002;21:199-216.
  101. Vuong lT, Dueker SR, Murphy SP. Plasma beta-carotene and retinol concentrations of children increase after a 30-d supplementation with the fruit Momordica cochinchinensis (gac). Am J Clin Nutr. 2002;75:872-79.
  102. Weinstock MA, Rossi JS, Redding CA, Maddock JE. Randomized Controlled Community Trial of the Efficacy of a Multicomponent Stage-Matched Intervention to Increase Sun Protection among Beachgoers. Prev Med. 2002;35:584-92.
  103. Williams AE, Maskarinec G, Franke AA, Stanczyk FZ. The temporal reliability of serum estrogens, progesterone, gonadotropins, SHBG and urinary estrogen and progesterone metabolites in premenopausal women. BMC Womens Health. 2002;2:13.
  104. Williams PG, Yoshida WY, Moore RE, Paul VJ. Isolation and structure determination of obyanamide, a novel cytotoxic cyclic depsipeptide from the marine cyanobacterium Lyngbya confervoides. J Nat Prod. 2002;65:29-31.
  105. Williams PG, Yoshida WY, Moore RE, Paul VJ. Tasiamide, a cytotoxic peptide from the marine cyanobacterium Symploca sp. J Nat Prod. 2002;65:1336-39.
  106. Williamson KS, Gabbita SP, Mou S, West M, Pye QN, Markesbery WR et al. The nitration product 5-nitro-gamma-tocopherol is increased in the Alzheimer brain. Nitric Oxide. 2002;6:221-27.
  107. Yee WL, Wang Q, Agdinaoay T, Dang K, Chang H, Grandinetti A et al. Green tea catechins decrease apolipoprotein B-100 secretion from HepG2 cells. Mol Cell Biochem. 2002;229:85-92.

<<Previous - Index
Next - In Press Publications>>


Back to Top


©2005 Cancer Research Center of Hawaii. All rights reserved.
Email Comments and Questions: webmaster@crch.hawaii.edu